Users Online: 413
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
DRUG REVIEW
Year : 2013  |  Volume : 2  |  Issue : 2  |  Page : 91-97

Crizotinib: A comprehensive review


1 Department of Medical Oncology, Tata Memorial Hospital, Ernest Borges Road, Parel, Mumbai, India
2 Department of Pathology, Tata Memorial Hospital, Ernest Borges Road, Parel, Mumbai, India

Correspondence Address:
Kumar Prabhash
Room No 304, 3rd floor, Homi Bhabha Block, Tata Memorial Hospital, Ernest Borges Road, Parel, Mumbai - 400 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-330X.110506

Rights and Permissions

Anaplastic lymphoma kinase (ALK) gene rearrangements are present in a small subset of non-small-cell lung cancers. ALK-positivity confers sensitivity to small-molecule ALK kinase inhibitors, such as crizotinib. The integration of crizotinib into standard treatment practice in NSCLC will rest on the widespread implementation of an effective screening system for newly diagnosed patients with NSCLC which is flexible enough to incorporate new targets as treatments are developed for them. Phase I and II studies of crizotinib in ALK-positive lung cancer have demonstrated significant activity and impressive clinical benefit, which led to its early approval by USFDA in 2011. Although crizotinib induces remissions and extends the lives of patients, there have been reports of emerging resistance to Crizotinib therapy. In this review, we discuss the history, mechanism of action, uses, adverse effects, dose modifications and future challenges and opportunities for patients with ALK-positive lung cancers.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3415    
    Printed86    
    Emailed1    
    PDF Downloaded927    
    Comments [Add]    
    Cited by others 13    

Recommend this journal